Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network.

MLA

Marchesi, Francesco, et al. “Comparison between Biosimilar Filgrastim vs Other Granulocyte-Colony Stimulating Factor Formulations (Originator Filgrastim, Peg-Filgrastim and Lenograstim) after Autologous Stem Cell Transplantation: A Retrospective Survey from the Rome Transplant Network.” British Journal of Haematology, vol. 169, no. 2, Apr. 2015, pp. 293–96. EBSCOhost, https://doi.org/10.1111/bjh.13199.

APA

Marchesi, F., Cerchiara, E., Dessanti, M. L., Gumenyuk, S., Franceschini, L., Palombi, F., Pisani, F., Romano, A., Spadea, A., Pupo, L., Annibali, O., La Malfa, A., Arcese, W., & Mengarelli, A. (2015). Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network. British Journal of Haematology, 169(2), 293–296. https://doi.org/10.1111/bjh.13199

Chicago

Marchesi, Francesco, Elisabetta Cerchiara, Maria Laura Dessanti, Svitlana Gumenyuk, Luca Franceschini, Francesca Palombi, Francesco Pisani, et al. 2015. “Comparison between Biosimilar Filgrastim vs Other Granulocyte-Colony Stimulating Factor Formulations (Originator Filgrastim, Peg-Filgrastim and Lenograstim) after Autologous Stem Cell Transplantation: A Retrospective Survey from the Rome Transplant Network.” British Journal of Haematology 169 (2): 293–96. doi:10.1111/bjh.13199.